20/20 HealthCare, Rcadia partner for coronary CTAs
20/20 HealthCare has entered an agreement with Rcadia for the distribution of the Rcadia COR-Analyzer, computer-aided detection software for automatic segmentation and classification of coronary CT angiogram (CTA) procedures.

The Jacksonville, Fla.-based company said it will use its wholly owned subsidiaries, Viztek and 20/20 HealthCare Global, as channels for achieving broad market and geographical distribution of the Rcadia solution.

According to 20/20, the COR Analyzer system detects stenotic lesions in the major coronary arteries and automatically identifies patients without coronary artery disease with a high negative predictive value.  It uses proprietary image processing algorithms to produce a fast and accurate evaluation report and accepts standard DICOM images from any 64-slice CT scanner.